• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS INC. THERAKOS CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS INC. THERAKOS CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Lot Number C132 / 813 -KIT
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Tingling (2171); Reaction (2414)
Event Date 01/21/2015
Event Type  Injury  
Event Description
The patient complained of tingling in her lips.Calcium gluconate 8.5% at 12ml per hour was administered iv into the return line of the cellex procedural kit by the physician due to use of the anticoagulant, acda, in the treatment.During the treatment, the patient complained about tingling in her lips.The physician increased the administration of the calcium gluconate to 14ml per hour.No further adjustments of the calcium, gluconate were made.The patient was stable at the time of the event.No service order was generated.The product was not returned for evaluation.
 
Manufacturer Narrative
A batch record review of lot c132 was conducted.There were no nonconformances associated with this lot.The lot met release requirements.Trends were reviewed for complaint category, other adverse event.In this case the other adverse event was tingling of the lips.There were no trends detected for this complaint category.No capa was initiated for this complaint category.Based on the medical assessment, the (b)(6) female with chronic gvhd developed tingling in her lips.The patient was on acda anticoagulant.The patient was administered calcium gluconate 8.5% at 12 ml per hour.This case is serious and related to ecp.The assessment is based on information available at the time of the investigation.No product was returned for investigation; therefore, it could not be determined if the product met specification based solely on the information provided by the customer.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted through the capa/continuous improvement process.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERAKOS CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX
Manufacturer (Section D)
THERAKOS INC.
bridgewater NJ
Manufacturer (Section G)
HARMAC MEDICAL PRODUCTS
2201 baily ave.
buffalo NY 14211
Manufacturer Contact
440 us route 22 east, suite 140
bridgewater, NJ 08807
MDR Report Key4493679
MDR Text Key15962738
Report Number2523595-2015-00024
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P680003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Nurse
Type of Report Initial
Report Date 01/21/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/01/2016
Device Lot NumberC132 / 813 -KIT
Other Device ID Number10705030100009
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/21/2015
Initial Date FDA Received02/06/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/01/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age42 YR
Patient Weight49
-
-